Bavarian Nordic Announces 2013 Full Year Results

Revenue and results were in line with the expectations for the year. As planned, the Company delivered 7 million doses of IMVAMUNE to the U.S. in 2013, of which 1.4 million doses relate to the new contract that was entered in above the original guidance.

http://ift.tt/1gQN3h7